Cargando…
PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity
Autores principales: | Lei, Guang, Horbath, Amber, Li, Zhuang, Gan, Boyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257991/ https://www.ncbi.nlm.nih.gov/pubmed/35674490 http://dx.doi.org/10.1002/cac2.12319 |
Ejemplares similares
-
ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
por: Gan, Boyi
Publicado: (2022) -
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022) -
Phospholipase iPLA2β acts as a guardian against ferroptosis
por: Mao, Chao, et al.
Publicado: (2021) -
Ferroptosis as an important driver of lupus
por: Mao, Chao, et al.
Publicado: (2021) -
A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers
por: Koppula, Pranavi, et al.
Publicado: (2022)